Noninvasive Blood Test Enables Early Detection of Prostate Cancer, Study Suggests

Noninvasive Blood Test Enables Early Detection of Prostate Cancer, Study Suggests
A new, noninvasive blood test can reliably detect prostate cancer in patients with inconclusive PSA tests, the test’s developer, CellMax Life, recently announced. Researchers say the company’s circulating tumor cell (CTC) blood test could reduce the number of unnecessary biopsies by up to 90 percent. A study highlighting the test’s positive results, titled, “Prospective clinical study

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *